Literature DB >> 26488328

Onyx Embolization for Isolated Type Dural Arteriovenous Fistula Using a Dual-Lumen Balloon Catheter.

Jin Woo Kim1, Byung Moon Kim, Keun Young Park, Dong Joon Kim, Dong Ik Kim.   

Abstract

BACKGROUND: Utilization of a dual-lumen balloon may improve Onyx penetration into isolated dural arteriovenous fistulas (i-DAVFs).
OBJECTIVE: To compare the results of Onyx embolization using a dual-lumen balloon with those using a non-balloon catheter for i-DAVFs.
METHODS: Twenty-nine patients underwent Onyx embolization for i-DAVFs using a non-balloon (n = 14) or a dual-lumen balloon catheter (n = 15). Since its introduction, a dual-lumen balloon catheter has been preferred. We compared the dual-lumen balloon group with the non-balloon catheter group regarding angiographic outcome, treatment-related complications, total procedural time, Onyx injection time, and the number of feeders requiring embolization.
RESULTS: The dual-lumen balloon group showed complete occlusion of i-DAVFs in 13 and near-complete in 2 patients, while the non-balloon group showed complete occlusion in 5, near-complete in 5, and incomplete in 4 patients (P < .05). Treatment-related complications occurred in 2 patients: 1 in the non-balloon group and 1 in the dual-lumen balloon group. The mean total procedural time was 62 ± 32 minutes in the dual-lumen balloon and 171 ± 88 minutes in the non-balloon group (P < .05). The mean Onyx injection time was 10 ± 6 minutes in the dual-lumen balloon and 49 ± 32 minutes in the non-balloon group (P < .05). The median number of feeders requiring embolization was 1 (range, 1-3) in the dual-lumen balloon and 2 (range, 1-4) in the non-balloon group (P < .05).
CONCLUSION: Utilization of a dual-lumen balloon catheter for Onyx embolization of i-DAVF seemed to significantly increase the immediate complete occlusion rate and decrease total procedural time, Onyx injection time, and number of feeders requiring embolization.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26488328     DOI: 10.1227/NEU.0000000000001069

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Single-session hematoma removal and transcortical venous approach for coil embolization of an isolated transverse-sigmoid sinus dural arteriovenous fistula in a hybrid operating room: illustrative case.

Authors:  Izumi Yamaguchi; Yasuhisa Kanematsu; Kenji Shimada; Nobuaki Yamamoto; Kazuhisa Miyake; Takeshi Miyamoto; Shu Sogabe; Eiji Shikata; Manabu Ishihara; Yuki Yamamoto; Kazutaka Kuroda; Yasushi Takagi
Journal:  J Neurosurg Case Lessons       Date:  2022-05-23

2.  Initial experience with the Scepter Mini catheter for the embolization of vascular malformations in the pediatric population.

Authors:  Stavros Matsoukas; Devin Bageac; Kurt Yaeger; Alejandro Berenstein; Johanna T Fifi; Tomoyoshi Shigematsu
Journal:  Neuroradiol J       Date:  2021-10-05

3.  Transarterial Treatment of Cranial Dural Arteriovenous Fistulas: The Role of Transarterial and Transvenous Balloon-Assisted Embolization.

Authors:  J O Zamponi; F P Trivelato; M T S Rezende; R K Freitas; L H de Castro-Afonso; G S Nakiri; T G Abud; A C Ulhôa; D G Abud
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-01       Impact factor: 3.825

4.  Single institution early clinical experience with the Scepter Mini balloon catheter.

Authors:  Timothy G White; Kevin A Shah; Justin Turpin; Amir R Dehdashti; Thomas Link; Jeffrey M Katz; Henry H Woo
Journal:  Neuroradiol J       Date:  2021-05-20

5.  Coil-Protected Technique for Liquid Embolization in Neurovascular Malformations.

Authors:  Keun Young Park; Jin Woo Kim; Byung Moon Kim; Dong Joon Kim; Joonho Chung; Chang Ki Jang; Jun Hwee Kim
Journal:  Korean J Radiol       Date:  2019-08       Impact factor: 3.500

6.  Scepter dual-lumen balloon catheter for Onyx embolization for dural arteriovenous fistula.

Authors:  Chang Ki Jang; Byung Moon Kim; Keun Young Park; Jae Whan Lee; Dong Joon Kim; Joonho Chung; Jun-Hwee Kim
Journal:  BMC Neurol       Date:  2021-01-20       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.